ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,922, issued on Aug. 25, was assigned to New York University (New York) and PureTech LYT Inc. (Boston).
"Anti-Galectin-9 antibodies and uses thereof" was invented by Shohei Koide (New York), George Miller (New York), Akiko Koide (New York), Linxiao Chen (New York), Aleksandra Filipovic (London), Eric Elenko (Boston) and Joseph Bolen (Boston).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are anti-Galectin-9 antibodies and methods of using in modulating (e.g., increasing) immune responses in a subject, either taken alone or in combination with an immune checkpoint inhibitor, such as a PD-1 inhibitor."
The patent was filed on March 25,...